Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to TamoxifenJennifer Bordeaux, David L. Rimm, Huan Cheng et al.|PLoS ONE|2012Cited by 62
High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung CarcinomasVamsidhar Velcheti, David L. Rimm, Kurt A. Schalper et al.|PLoS ONE|2013Cited by 48
In Situ Quantitative Measurement of HER2mRNA Predicts Benefit from Trastuzumab-Containing Chemotherapy in a Cohort of Metastatic Breast Cancer PatientsMaria Vassilakopoulou, Amanda Psyrri, Jennifer Bordeaux et al.|PLoS ONE|2014Cited by 27
Comparison of HER2 and Phospho-HER2 Expression between Biopsy and Resected Breast Cancer Specimens Using a Quantitative Assessment MethodYalai Bai, David F. Stern, Huan Cheng et al.|PLoS ONE|2013Cited by 19
Abstract 691: Estrogen receptor mRNA level in breast cancer predicts response to tamoxifenJennifer Bordeaux, David L. Rimm, Huan Cheng et al.|Cancer Research|2012Cited by 0